Organovo Sells FXR Program to Eli Lilly with Paul Hastings' Support
Deal News | Mar 26, 2025 | Paul Hastings
Organovo Holdings, Inc., a clinical-stage biotechnology company known for its focus on developing new treatment methodologies for inflammatory bowel disease, has transferred its FXR program to Eli Lilly and Company. The FXR program's flagship asset, FXR314, is included in this transaction. Paul Hastings LLP, a renowned law firm, acted as the legal advisor for Organovo in this deal. The chair of the Palo Alto Corporate Department, Jeff Hartlin, alongside partner Samantha Eldredge, spearheaded the legal team, which included other team members such as partners Lucas Rachuba, Todd Schneider, and associates Maggie Chou and Daniel Jun. This move reflects Organovo's strategic positioning in the biotechnology arena, supported by Paul Hastings' global expertise.
Sectors
- Biotechnology
- Legal Services
- Pharmaceuticals
Geography
- United States – Both Organovo Holdings and Eli Lilly are based in the United States, and Paul Hastings has a significant presence there, particularly through its Palo Alto office.
Industry
- Biotechnology – Organovo operates within the biotechnology sector, developing treatments for diseases such as inflammatory bowel disease.
- Legal Services – Paul Hastings provided legal advisory services for the transaction, showcasing their involvement in corporate law and transactions.
- Pharmaceuticals – Eli Lilly, a major player in the pharmaceuticals industry, is involved in acquiring biotech assets to enhance its product offerings.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Organovo Holdings, Inc. | Selling Company | Company | A biotechnology company focused on developing innovative treatments for inflammatory bowel disease. |
| Eli Lilly and Company | Buying Company | Company | A global pharmaceutical company acquiring Organovo's FXR program. |
| Paul Hastings LLP | Legal Advisor | Company | A premier law firm known for providing expert legal services globally. |
| Jeff Hartlin | Lead Legal Advisor | Person | Chair of the Palo Alto Corporate Department at Paul Hastings, leading the legal team for this transaction. |
| Samantha Eldredge | Partner, Legal Advisor | Person | Partner at Paul Hastings involved in advising Organovo during the transaction. |